Enlivex Ltd.

ENLV chart

Enlivex Ltd. news

• Enlivex stock: Allocetra trial reports durable 12-month response

  ad-hoc-news.de · Nov 10, 7:27 AM EST

• Enlivex Ltd. (ENLV) Seasonal returns chart

  Yahoo Finance Australia · Nov 9, 10:42 PM EST

• Weekly Recap: Higher response and no treatment-related serious events

  TradingView · Nov 9, 6:00 AM EST

• Enlivex stock trades at 1.14 euros on Lang & Schwarz

  ad-hoc-news.de · Nov 8, 7:13 AM EST

• Enlivex Therapeutics Ltd (1BT.SG) Seasonal returns chart - Yahoo Finance

  Yahoo Finance Singapore · Nov 6, 3:55 PM EST

• Enlivex Ltd. (1BT.F) Seasonal Returns Chart - Yahoo Finance

  Yahoo! Finance Canada · Nov 6, 2:04 AM EST

• Enlivex stock trades at 1.25 euros on November 5

  ad-hoc-news.de · Nov 5, 7:37 AM EST

• Why Are 5 Oversold Names Sinking: Enlivex Therapeutics (NASDAQ:ENLV), Cheetah Net Supply Chain Service (NASDAQ:CTNT), Robin Energy (NASDAQ:RBNE), Magic Empire Global (NASDAQ:MEGL) and Children's Place (NASDAQ:PLCE)?

  kalkine.ca · Nov 4, 11:55 AM EST

• Which Oversold Stock Faces Most Pressure: Cheetah Net Supply Chain Service (NASDAQ:CTNT), Enlivex Therapeutics (NASDAQ:ENLV), Magic Empire Global (NASDAQ:MEGL), Robin Energy (NASDAQ:RBNE) or XMAX Inc. (NASDAQ:XMAX)?

  kalkine.ca · Nov 4, 11:55 AM EST

• Enlivex Announces Favorable 12-Month Topline Data from Phase I/IIa Allocetra Trial, Demonstrating Durable Treatment Response

  Yahoo Finance · Nov 2, 8:00 AM EST

• Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

  Yahoo Finance · Oct 28, 8:00 AM EDT

• Enlivex Ltd. (ENLV) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

  Yahoo Finance · Sep 1, 9:55 AM EDT

Enlivex Ltd. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-11-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-22
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-10-19
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-29
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-25
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-22
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-11
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-30
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-29
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-28

About Enlivex Ltd.

Ticker

ENLV (Nasdaq)

Industry

Finance Services

Headquarters

Tel Aviv

Incorporated in

Israel

Fiscal year end

December 31

SEC CIK

1596812

Former names

Enlivex Therapeutics Ltd., Bioblast Pharma Ltd., BIO BLAST PHARMA LTD.

Frequently asked questions